Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.

AstraZeneca (AZ) and Amgen have shared positive results from a late-stage study of Tezspire (tezepelumab) in patients with ...

Aquestive Therapeutics (AQST – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram ...

With multiple clinical stage product candidates in Phase 2 and Phase 3 development, each from a new class of potential intranasal therapies that we call pherines, each has a differentiated mechanism ...

On Saturday, Denmark-based ALK entered into a strategic license agreement with ARS Pharmaceuticals, Inc. (NASDAQ:SPRY). The agreement grants ALK exclusive global rights to the neffy adrenaline ...

CCHR says the VA and DoD waste billions of dollars on treatments that contribute to high suicide rates, sudden deaths and ...

Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...

The randomized, double-blind WAYPOINT trial tested Tezspire’s efficacy and safety in adults with severe CRSwNP who continued ...

Oliver Watson, a budding young goalkeeper from Royston, near Barnsley, is set to feature in the first episode of Yorkshire ...

Discover the similarities between Covid, flu, and the common cold, and learn how to diagnose each one accurately with testing ...